Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ridgway

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Developments in Biological Standardization|January 1, 1996
Regulatory expectation for data on viral testing and process evaluation for phase I studies and product licensing in the United States, Europe and JapanA Ridgway
Developments in Biologicals|November 19, 2002
A Canadian perspective on assessing comparability of biotechnology productsA Ridgway
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1995
Regulation of gene therapy: the Canadian approachA Ridgway
Developments in Biologicals|November 19, 2003
Canadian perspectives on expectations for process validationA Ridgway
Biotechnology (Reading, Mass.)|January 1, 1988
Mammalian expression vectorsA A Ridgway
Journal of the Royal Society of Medicine|June 1, 1982
Adult-onset Still's diseaseH A Ridgway
Gene|November 16, 1992
Reticuloendotheliosis virus long terminal repeat elements are efficient promoters in cells of various species and tissue origin, including human lymphoid cellsA A Ridgway
Transfusion Science|February 7, 1996
A rational approach to regulation of gene therapy in CanadaK Bailey, A Ridgway
Eye (London, England)|January 1, 1995
Lattice dystrophy and corneal ulcerationK Goodall, A Brahma, A Ridgway
The British Journal of Dermatology|July 1, 1979
Multicentric reticulohistiocytosis with carcinoma-in-situ of the cervixH A Ridgway, E L Rhodes
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Developments in Biological Standardization|January 1, 1996
Regulatory expectation for data on viral testing and process evaluation for phase I studies and product licensing in the United States, Europe and JapanA Ridgway
Developments in Biologicals|November 19, 2002
A Canadian perspective on assessing comparability of biotechnology productsA Ridgway
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1995
Regulation of gene therapy: the Canadian approachA Ridgway
Developments in Biologicals|November 19, 2003
Canadian perspectives on expectations for process validationA Ridgway
Biotechnology (Reading, Mass.)|January 1, 1988
Mammalian expression vectorsA A Ridgway
Journal of the Royal Society of Medicine|June 1, 1982
Adult-onset Still's diseaseH A Ridgway
Gene|November 16, 1992
Reticuloendotheliosis virus long terminal repeat elements are efficient promoters in cells of various species and tissue origin, including human lymphoid cellsA A Ridgway
Transfusion Science|February 7, 1996
A rational approach to regulation of gene therapy in CanadaK Bailey, A Ridgway
Eye (London, England)|January 1, 1995
Lattice dystrophy and corneal ulcerationK Goodall, A Brahma, A Ridgway
The British Journal of Dermatology|July 1, 1979
Multicentric reticulohistiocytosis with carcinoma-in-situ of the cervixH A Ridgway, E L Rhodes
Pageof 12